H. Autorité and D. Santé, Ostéodensitométrie [absorptiométrie osseuse] sur 2 sites, par méthode biphotonique. Mis à jour le 21 juin, 2006.

. Loi, relative à la politique de santé publique, Journal Officiel, vol.11, 2004.

S. R. Cummings and L. J. Melton, Epidemiology and outcomes of osteoporotic fractures, The Lancet, vol.359, issue.9319, pp.1761-1768, 2002.
DOI : 10.1016/S0140-6736(02)08657-9

C. Holroyd, C. Cooper, and E. Dennison, Epidemiology of osteoporosis, Best Practice & Research Clinical Endocrinology & Metabolism, vol.22, issue.5, pp.671-85, 2008.
DOI : 10.1016/j.beem.2008.06.001

R. Levasseur, J. Sabatier, and C. Marcelli, Physiopathologie de l'ost??oporose, La Revue de M??decine Interne, vol.25, pp.531-538, 2004.
DOI : 10.1016/S0248-8663(04)80051-1

A. Stevens and J. Lowe, Histologie humaine De Boeck Supérieur, pp.234-278, 1997.

M. Quemerais-durieu, V. Kerlan, and O. Chabre, Innovations th??rapeutiques dans l???ost??oporose (anticorps antiscl??rostine et denosumab), Annales d'Endocrinologie, vol.72, pp.15-22, 2011.
DOI : 10.1016/S0003-4266(11)70005-1

T. D. Rachner, S. Khosla, and L. C. Hofbauer, Osteoporosis: now and the future, The Lancet, vol.377, issue.9773, pp.1276-87, 2011.
DOI : 10.1016/S0140-6736(10)62349-5

N. Alos and F. Rauch, Acquisition de la masse osseuse chez l???enfant : physiopathologie et ??valuation, Archives de P??diatrie, vol.16, issue.6, pp.591-594, 2009.
DOI : 10.1016/S0929-693X(09)74078-3

F. Debiais, G??n??tique et m??tabolisme osseux, Revue du Rhumatisme Monographies, vol.77, issue.4, pp.307-320, 2010.
DOI : 10.1016/j.monrhu.2010.07.002

M. Audran, E. Legrand, D. Chappard, and M. Basle, Physiopathologie de l'ost??oporose. Cons??quences biom??caniques axiales de l'ost??op??nie et des modifications architecturales, Annales de R??adaptation et de M??decine Physique, vol.38, issue.5, pp.259-63, 1995.
DOI : 10.1016/0168-6054(96)89326-3

S. Cusack and K. D. Cashman, Impact of genetic variation on metabolic response of bone to diet, Proceedings of the Nutrition Society, vol.60, issue.04, pp.901-913, 2003.
DOI : 10.1002/jbmr.5650110304

S. Roux, New treatment targets in osteoporosis, Joint Bone Spine, vol.77, issue.3, pp.222-230, 2010.
DOI : 10.1016/j.jbspin.2010.02.004

E. Sornay-rendu, S. Boutroy, F. Munoz, and P. D. Delmas, Alterations of Cortical and Trabecular Architecture Are Associated With Fractures in Postmenopausal Women, Partially Independent of Decreased BMD Measured by DXA: The OFELY Study, Journal of Bone and Mineral Research, vol.312, issue.3, pp.425-458, 2007.
DOI : 10.1359/jbmr.061206

D. Curran, M. Maravic, P. Kiefer, V. Tochon, and P. Fardellone, Epidemiology of osteoporosis-related fractures in France: A literature review, Joint Bone Spine, vol.77, issue.6, pp.546-51, 2010.
DOI : 10.1016/j.jbspin.2010.02.006

O. Johnell and J. A. Kanis, An estimate of the worldwide prevalence and disability associated with osteoporotic fractures, Osteoporosis International, vol.16, issue.suppl 2, pp.1726-1759, 2006.
DOI : 10.1007/s00198-006-0172-4

M. Maravic, C. Le-bihan, P. Landais, and P. Fardellone, Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-80, 2005.
DOI : 10.1007/s00198-005-2031-0

D. Bliuc, N. D. Nguyen, V. E. Milch, T. V. Nguyen, J. A. Eisman et al., Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women, JAMA, vol.301, issue.5, pp.513-534, 2009.
DOI : 10.1001/jama.2009.50

P. Dargent-molina, ??pid??miologie et facteurs de risque d' ost??oporose, La Revue de M??decine Interne, vol.25, pp.517-542, 2004.
DOI : 10.1016/S0248-8663(04)80049-3

F. Grados, C. Marcelli, P. Dargent-molina, C. Roux, J. F. Vergnol et al., Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study, Bone, vol.34, issue.2, pp.362-369, 2004.
DOI : 10.1016/j.bone.2003.11.008

C. Cooper, E. J. Atkinson, S. J. Jacobsen, W. M. O-'fallon, and L. J. Melton, Population-Based Study of Survival after Osteoporotic Fractures, American Journal of Epidemiology, vol.137, issue.9, pp.1001-1006, 1993.
DOI : 10.1093/oxfordjournals.aje.a116756

H. Autorité and D. Santé, Prévention, diagnostic et traitement de l'ostéoporose. Mis à jour en juillet, 2006.

B. Cortet, L'ost??oporose??: aujourd'hui et??demain, Revue du Rhumatisme, vol.73, issue.8, pp.791-795, 2006.
DOI : 10.1016/j.rhum.2006.06.001

P. Dargent-molina and G. Bréart, Epidemiology of falls and fall-related injuries in the aged, Rev Epidemiol Sante Publique, vol.43, pp.72-83, 1995.

P. Dargent-molina, F. Favier, H. Grandjean, C. Baudoin, A. M. Schott et al., Fall-related factors and risk of hip fracture: the EPIDOS prospective study, The Lancet, vol.348, issue.9021, pp.145-154, 1996.
DOI : 10.1016/S0140-6736(96)01440-7

K. Briot, B. Cortet, T. Thomas, M. Audran, H. Blain et al., 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.3, pp.304-317, 2012.
DOI : 10.1016/j.jbspin.2012.02.014

J. Pouillès, F. A. Trémollieres, and C. Ribot, Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: Physical and biochemical characteristics, Osteoporosis International, vol.68, issue.2, pp.193-200, 2006.
DOI : 10.1007/s00198-005-1954-9

C. Tannenbaum, J. Clark, K. Schwartzman, S. Wallenstein, R. Lapinski et al., Yield of Laboratory Testing to Identify Secondary Contributors to Osteoporosis in Otherwise Healthy Women, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.10, pp.4431-4438, 2002.
DOI : 10.1210/jc.2002-020275

C. Frayssinet and F. Trémollieres, Ost??oporose postm??nopausique??: quand faut-il demander un bilan biologique??? En quoi consiste-t-il???, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.6, pp.656-664, 2008.
DOI : 10.1016/j.gyobfe.2008.04.005

E. Biver, F. Chopin, G. Coiffier, T. F. Brentano, B. Bouvard et al., Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis, Joint Bone Spine, vol.79, issue.1, pp.20-25, 2012.
DOI : 10.1016/j.jbspin.2011.05.003

F. Chopin, E. Biver, T. Funck-brentano, B. Bouvard, G. Coiffier et al., Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.1, pp.26-31, 2012.
DOI : 10.1016/j.jbspin.2011.05.004

J. Haymann, Ost??odensitom??trie??: principes et indications, Progr??s en Urologie - FMC, vol.20, issue.4, pp.119-141, 2010.
DOI : 10.1016/j.fpurol.2010.05.003

S. Kolta, Densitometrie : indications, technique, resultats, controle de qualite, Journal de Radiologie, vol.89, issue.10, p.1257, 2008.
DOI : 10.1016/S0221-0363(08)75744-5

. Agence-nationale-d, accréditation et d'évaluation en santé Diagnostic de l'ostéoporose en rhumatologie chez les femmes ménopausées

E. Legrand, B. Bouvard, and E. Hoppé, Ost??oporoses??: g??n??ralit??s, strat??gie diagnostique, EMC - Appareil locomoteur, vol.7, issue.2, pp.1-5, 2012.
DOI : 10.1016/S0246-0521(12)51756-0

E. M. Lewiecki, N. B. Watts, M. R. Mcclung, S. M. Petak, L. K. Bachrach et al., Official Positions of the International Society for Clinical Densitometry, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.8, pp.3651-3656, 2004.
DOI : 10.1210/jc.2004-0124

J. E. Rossouw, G. L. Anderson, R. L. Prentice, A. Z. Lacroix, C. Kooperberg et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, vol.288, pp.321-354, 2002.

J. A. Kanis, O. Johnell, A. Oden, H. Johansson, and E. Mccloskey, FRAX??? and the assessment of fracture probability in men and women from the UK, Osteoporosis International, vol.17, issue.Suppl 2, pp.385-97, 2008.
DOI : 10.1007/s00198-007-0543-5

C. Roux and T. Thomas, Optimal use of FRAX??, Joint Bone Spine, vol.76, issue.1, pp.1-3, 2009.
DOI : 10.1016/j.jbspin.2008.11.001

URL : https://hal.archives-ouvertes.fr/inserm-00395611

P. Fardellone, J. L. Sebert, M. Bouraya, O. Bonidan, G. Leclercq et al., Evaluation of the calcium content of diet by frequential self-questionnaire, Rev Rhum Mal Osteoartic, vol.58, pp.99-103, 1991.

F. Canoui-poitrine, S. Jaglal, R. Chapurlat, V. Tainturier, C. Colin et al., Has reimbursement of bone mineral density testing and anti-osteoporotic treatments improved management of osteoporosis in France?, Bone, vol.47, issue.4, pp.790-794, 2010.
DOI : 10.1016/j.bone.2010.06.026

M. E. Arlot, E. Sornay-rendu, P. Garnero, B. Vey-marty, and P. D. Delmas, Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort, Journal of Bone and Mineral Research, vol.8, issue.suppl 1, pp.683-90, 1997.
DOI : 10.1359/jbmr.1997.12.4.683

P. Fardellone, F. Cotté, C. Roux, E. Lespessailles, F. Mercier et al., Calcium intake and the risk of osteoporosis and fractures in French women, Joint Bone Spine, vol.77, issue.2, pp.154-162, 2010.
DOI : 10.1016/j.jbspin.2009.08.007

E. Loppin, M. Freslon, S. Rigouard, F. Pentecôte, G. Durand et al., D??pistage d'une ost??oporose chez??200??femmes m??nopaus??es ayant une??fracture p??riph??rique non f??morale, Revue du Rhumatisme, vol.74, issue.10-11, pp.1070-1071, 2007.
DOI : 10.1016/j.rhum.2007.10.081

. Gaudin, Prevalence and features of osteoporosis in the French general population: The Instant study, Joint Bone Spine, vol.76, pp.394-400, 2009.

H. Blain, S. Chevallier, E. Nogué, M. Picot, M. Amouyal et al., ??valuation de la pratique des m??decins g??n??ralistes pour le d??pistage et le traitement de l???ost??oporose chez les femmes de 60ans et plus, Revue du Rhumatisme, vol.80, issue.6, pp.594-602, 2013.
DOI : 10.1016/j.rhum.2013.02.004

M. Maravic, P. Benamou, M. Bensaber, D. Duplantier, P. Lebrun et al., Évaluation des pratiques professionnelles. À propos de la prescription de l'ostéodensitométrie chez la femme ménopausée, Rev Rhum, vol.77, pp.643-650, 2010.

. Agence-nationale-d, accréditation et d'évaluation en santé Agence Française de la sécurité sanitaire des produits de santé. Traitements hormonaux substitutifs de la ménopause -Argumentaire. Mis à jour le 11 mai, Disponible sur http, 2004.

C. Roux, P. Fardellone, E. Lespessailles, F. Cotté, F. Mercier et al., Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT study, Joint Bone Spine, vol.75, issue.6, pp.702-78, 2008.
DOI : 10.1016/j.jbspin.2007.12.007

N. Amamra, C. Berr, F. Clavel-chapelon, C. Delcourt, P. D. Delmas et al., Estimated number of women likely to benefit from bone mineral density measurement in France, Joint Bone Spine, vol.71, issue.5, pp.409-427, 2004.
DOI : 10.1016/j.jbspin.2003.11.007

URL : https://hal.archives-ouvertes.fr/inserm-00168648

K. D. Ward and R. C. Klesges, A meta-analysis of the effects of cigarette smoking on bone mineral density, Calcified Tissue International, vol.48, issue.2A, pp.259-70, 2001.
DOI : 10.1007/BF02390832

M. Touvier, S. Lioret, I. Vanrullen, J. Boclé, M. Boutron-ruault et al., Vitamin and Mineral Inadequacy in the French Population: Estimation and Application for the Optimization of Food Fortification, International Journal for Vitamin and Nutrition Research, vol.76, issue.6, pp.343-51, 2006.
DOI : 10.1024/0300-9831.76.6.343

H. Autorité and D. Santé, Utilité clinique du dosage de la vitamine D. Mis en ligne le 30 octobre 2013. [En ligne]. Disponible sur http

T. Dorner, K. Lawrence, E. Rebhandl, E. Weichselbaum, and A. Rieder, Meinungen und Einstellungen ??sterreichischer Allgemeinmedizinerinnen und Allgemeinmediziner zu Osteoporose, Wiener Medizinische Wochenschrift, vol.34, issue.10 Suppl, pp.247-52, 2009.
DOI : 10.1007/s10354-009-0648-x

P. F. Schnatz, K. A. Marakovits, M. Dubois, and D. M. Sullivan, Osteoporosis screening and treatment guidelines, Menopause, vol.18, issue.10, pp.1072-1080, 2011.
DOI : 10.1097/gme.0b013e318215101a

K. H. Rubin, B. Abrahamsen, A. P. Hermann, M. Bech, J. Gram et al., Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study, Osteoporosis International, vol.20, issue.5, pp.1401-1410, 2011.
DOI : 10.1007/s00198-010-1348-5

G. Chami, L. Jeys, M. Freudmann, L. Connor, and M. Siddiqi, Are osteoporotic fractures being adequately investigated?: A questionnaire of GP & orthopaedic surgeons, BMC Family Practice, vol.103, issue.5, p.7, 2006.
DOI : 10.3109/03009749609103753

M. Duyvendak, M. Naunton, E. N. Van-roon, and J. R. Brouwers, Doctors??? beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention, Journal of Clinical Pharmacy and Therapeutics, vol.116, issue.5 Suppl., pp.356-66, 2011.
DOI : 10.1111/j.1365-2710.2010.01185.x

S. R. Majumdar, L. M. Lix, M. Yogendran, S. N. Morin, C. J. Metge et al., Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998???2008), The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.4, pp.1236-1278, 1998.
DOI : 10.1210/jc.2011-2645

S. B. Jaglal, I. Weller, M. Mamdani, G. Hawker, H. Kreder et al., Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong?, Journal of Bone and Mineral Research, vol.57, issue.S1, pp.898-905, 2005.
DOI : 10.1359/JBMR.041231

P. E. Goss, J. N. Ingle, S. Martino, N. J. Robert, H. B. Muss et al., A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer, New England Journal of Medicine, vol.349, issue.19, pp.1793-1802, 2003.
DOI : 10.1056/NEJMoa032312

P. E. Goss, J. N. Ingle, S. Martino, N. J. Robert, H. B. Muss et al., Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17, JNCI Journal of the National Cancer Institute, vol.97, issue.17, pp.1262-71, 2005.
DOI : 10.1093/jnci/dji250

R. C. Coombes, E. Hall, L. J. Gibson, R. Paridaens, J. Jassem et al., A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer, New England Journal of Medicine, vol.350, issue.11, pp.1081-92, 2004.
DOI : 10.1056/NEJMoa040331

M. Baum, A. U. Budzar, J. Cuzick, J. Forbes, J. H. Houghton et al., Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet, vol.359, pp.2131-2140, 2002.

A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett et al., Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer, of the ATAC Lancet, vol.365, pp.60-62, 2005.

R. E. Coleman, L. M. Banks, S. I. Girgis, L. S. Kilburn, E. Vrdoljak et al., Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study, The Lancet Oncology, vol.8, issue.2, pp.119-146, 2007.
DOI : 10.1016/S1470-2045(07)70003-7

T. Arimidex, J. F. Forbes, J. Cuzick, A. Buzdar, A. Howell et al., Alone or in Combination (ATAC) Trialists' Group Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial, Lancet Oncol, vol.9, pp.45-53, 2008.

R. C. Coombes, L. S. Kilburn, C. F. Snowdon, R. Paridaens, R. E. Coleman et al., Survival and safety of exemestane versus tamoxifen after 2???3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial, The Lancet, vol.369, issue.9561, pp.559-70, 2007.
DOI : 10.1016/S0140-6736(07)60200-1

B. Thürlimann, A. Keshaviah, A. S. Coates, H. Mouridsen, L. Mauriac et al., A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, vol.353, pp.2747-57, 2005.

R. Gynécomed-ile-de-france, Traitements hormonaux adjuvants des cancers du sein. [En ligne]. Disponible sur http

E. Sornay-rendu, F. Munoz, P. Garnero, F. Duboeuf, and P. D. Delmas, Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study, Journal of Bone and Mineral Research, vol.18, issue.Suppl 6, pp.1813-1822, 2005.
DOI : 10.1359/JBMR.050609

B. Shea, G. Wells, A. Cranney, N. Zytaruk, V. Robinson et al., Calcium supplementation on bone loss in postmenopausal women, Cochrane Database Syst Rev, 2004.

B. M. Tang, G. D. Eslick, C. Nowson, C. Smith, and . Bensoussan, Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis, The Lancet, vol.370, issue.9588, pp.657-66, 2007.
DOI : 10.1016/S0140-6736(07)61342-7

C. Roux, Ostéopénie: la fin d'une méprise, La Lettre du Rhumatologue, vol.391, pp.31-33, 2013.

A. Pressman, B. Forsyth, B. Ettinger, and A. N. Tosteson, Initiation of Osteoporosis Treatment after Bone Mineral Density Testing, Osteoporosis International, vol.12, issue.5, pp.337-379, 2001.
DOI : 10.1007/s001980170099

S. M. Cadarette, M. A. Gignac, S. B. Jaglal, D. E. Beaton, and G. A. Hawker, Access to Osteoporosis Treatment is Critically Linked to Access to Dual-Energy X-ray Absorptiometry Testing, Medical Care, vol.45, issue.9, pp.896-901, 2007.
DOI : 10.1097/MLR.0b013e318054689f